Skip to content
Governance Register

← US public companies

Dice Therapeutics, Inc.

SEC CIK 1645569 · DICE · last insider filing 2023-08-09

Directors (from insider filings)

NameCapacity as filedFilings
Scheller Richard H Director filed 2021 - 2023
RA Capital Healthcare Fund LP Director filed 2021 - 2023
Tetlow Sharon Director filed 2021 - 2023
RA Capital Management, LLC Director filed 2021 - 2023
Scopa James Paul Director filed 2021 - 2023
Kolchinsky Peter Director filed 2021 - 2023
Shah Rajeev M. Director filed 2021 - 2023
Judice Kevin Director · CEO filed 2021 - 2023
RA Capital Nexus Fund II, L.P. Director filed 2021 - 2023
Simson Jake Director filed 2021 - 2023
Bowers Lisa Director filed 2022 - 2023
Doyle Mittie Director filed 2022 - 2023
Zachary Stephen Director filed 2021 - 2021
Gandhi Shaan-Chirag C Director filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Timothy Lu CMO filed 2021 - 2023
Jacobsen John R. CSO filed 2021 - 2023
Robertson Scott M. CFO & CBO filed 2021 - 2023

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.